BlackRock Institutional Trust’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
BFA
RC
BC
NI
SFM
BlackRock Institutional Trust's ANGO Position: Q4 2016 in Review
BlackRock Institutional Trust increased its AngioDynamics (ANGO) stake by 6.2% in Q4 2016, buying an estimated $921K and bringing the position to 949,289 shares worth $16M. The position accounts for ﹤0.01% of the portfolio, ranked #2129.
BlackRock Institutional Trust first reported a position in ANGO in Q2 2013 and has held it in 15 quarters since. The position peaked at $16.1M in Q4 2013. 151 funds tracked by Wall St. Rank hold ANGO as of Q4 2016.
- BlackRock Institutional Trust held 949,289 shares of AngioDynamics worth $16M as of Q4 2016.
- BlackRock Institutional Trust bought 55,249 AngioDynamics shares in Q4 2016, an estimated $921K.
- AngioDynamics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2129 holding.
- BlackRock Institutional Trust first reported a position in AngioDynamics in Q2 2013 and has held it in 15 quarters since.
- BlackRock Institutional Trust's AngioDynamics position peaked at $16.1M in Q4 2013.
- 151 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2016.
Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.